Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 248

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Comparative Pharmacokinetics and Pharmacodynamics of Short-Acting Hypnosedatives: Zaleplon, Zolpidem and Zopiclone

Drover, David R·2004·Clinical Pharmacokinetics

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2165/00003088-200443040-00002

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 94

  1. Mendelson, 1995, Drug Saf, 13, 257, 10.2165/00002018-199513040-00005 · DOI
  2. George, 2001, Lancet, 358, 1623, 10.1016/S0140-6736(01)06656-9 · DOI
  3. Sieghart, 2002, Curr Top Med Chem, 2, 795, 10.2174/1568026023393507 · DOI · Paper page
  4. Sieghart, 1995, Pharmacol Rev, 47, 181
  5. Terzano, 2003, Drug Saf, 26, 261, 10.2165/00002018-200326040-00004 · DOI · Paper page
  6. Wagner, 2000, Sleep Med Rev, 4, 551, 10.1053/smrv.2000.0126 · DOI
  7. Weitzel, 2000, Clin Ther, 22, 1254, 10.1016/S0149-2918(00)83024-6 · DOI · Paper page
  8. Dooley, 2000, Drugs, 60, 413, 10.2165/00003495-200060020-00014 · DOI · Paper page
  9. Hoehns, 1993, Clin Pharm, 12, 814
  10. Langtry, 1990, Drugs, 40, 291, 10.2165/00003495-199040020-00008 · DOI · Paper page
  11. Goa, 1986, Drugs, 32, 48, 10.2165/00003495-198632010-00003 · DOI
  12. Noble, 1998, Drugs, 55, 277, 10.2165/00003495-199855020-00015 · DOI · Paper page
  13. Kales, 1991, Clin Pharmacol Ther, 49, 468, 10.1038/clpt.1991.55 · DOI · Paper page
  14. Kales, 1983, Pharmacology, 26, 138, 10.1159/000137795 · DOI
  15. Damgen, 1999, Neurosci Res Commun, 25, 139, 10.1002/(SICI)1520-6769(199911/12)25:3<139::AID-NRC3>3.0.CO;2-W · DOI
  16. Sanger, 1988, Neuropharmacology, 27, 1125, 10.1016/0028-3908(88)90007-X · DOI
  17. Vanover, 1994, Psychopharmacology (Berl), 115, 289, 10.1007/BF02245068 · DOI
  18. Day, 1992, Soc Neurosci, 18, 725
  19. Griebel, 1999, Psychopharmacology (Berl), 146, 205, 10.1007/s002130051108 · DOI
  20. Noguchi, 2002, Eur J Pharmacol, 434, 21, 10.1016/S0014-2999(01)01502-3 · DOI
  21. Drover, 2000, Clin Ther, 22, 1443, 10.1016/S0149-2918(00)83043-X · DOI
  22. McMahon, 2002, J Pharmacol Exp Ther, 300, 505, 10.1124/jpet.300.2.505 · DOI
  23. Sanger, 1997, Behav Pharmacol, 8, 287, 10.1097/00008877-199708000-00002 · DOI
  24. Sanger, 1995, Behav Pharmacol, 6, 116, 10.1097/00008877-199503000-00003 · DOI
  25. Davies, 2000, Mol Pharmacol, 58, 756, 10.1124/mol.58.4.756 · DOI
  26. Blanchard, 1983, Biochem Pharmacol, 32, 3651, 10.1016/0006-2952(83)90318-0 · doi:10.1016/0006-2952(83)90318-0
  27. Blanchard, 1979, Life Sci, 24, 2417, 10.1016/0024-3205(79)90449-1 · DOI
  28. Visser, 2003, J Pharmacol Exp Ther, 304, 1251, 10.1124/jpet.102.044859 · DOI
  29. Visser, 2003, J Pharmacol Exp Ther, 304, 88, 10.1124/jpet.102.042341 · DOI
  30. Follesa, 2002, Neuropharmacology, 42, 191, 10.1016/S0028-3908(01)00167-8 · DOI
  31. Danjou, 1999, Br J Clin Pharmacol, 48, 367, 10.1046/j.1365-2125.1999.00024.x · DOI
  32. Walsh, 2000, Clin Neuropharmacol, 23, 17, 10.1097/00002826-200001000-00004 · DOI
  33. Vermeeren, 2002, Sleep, 25, 224
  34. Hedner, 2000, Int J Geriatr Psychiatry, 15, 704, 10.1002/1099-1166(200008)15:8<704::AID-GPS183>3.0.CO;2-S · DOI
  35. Elie, 1999, J Clin Psychiatry, 60, 536, 10.4088/JCP.v60n0806 · DOI · Paper page
  36. Uchiumi, 2000, Nihon Shinkei Seishin Yakurigaku Zasshi, 20, 123
  37. Hemmeter, 2000, Psychopharmacology (Berl), 147, 384, 10.1007/s002130050007 · DOI
  38. Nakajima, 2000, Life Sci, 67, 81, 10.1016/S0024-3205(00)00603-2 · DOI
  39. Hajak, 1999, Drug Saf, 21, 457, 10.2165/00002018-199921060-00003 · DOI · Paper page
  40. Hajak, 1994, Int Clin Psychopharmacol, 9, 251, 10.1097/00004850-199400940-00004 · DOI
  41. Voderholzer, 2001, Eur Arch Psychiatry Clin Neurosci, 251, 117, 10.1007/s004060170045 · DOI
  42. Sanger, 1996, Eur J Pharmacol, 313, 35, 10.1016/0014-2999(96)00510-9 · DOI
  43. Gaudreault, 1995, Pharm Res, 12, 1592, 10.1023/A:1016224629614 · DOI
  44. Griebel, 1999, Pharmacol Biochem Behav, 62, 689, 10.1016/S0091-3057(98)00209-3 · DOI
  45. Lobarinas, 2000, Psychopharmacology (Berl), 149, 176, 10.1007/s002139900354 · doi:10.1007/s002139900354
  46. Depoortere, 1986, J Pharmacol Exp Ther, 237, 649
  47. Berson, 2001, J Pharmacol Exp Ther, 299, 793, 10.1016/S0022-3565(24)29292-2 · DOI
  48. Griebel, 1998, J Psychopharmacol, 12, 356, 10.1177/026988119801200405 · DOI
  49. Carlson, 2001, Eur J Pharmacol, 415, 181, 10.1016/S0014-2999(01)00851-2 · DOI
  50. Ghoneim, 1981, Psychopharmacology, 73, 147, 10.1007/BF00429206 · DOI
  51. Curran, 1986, Biol Psychol, 23, 179, 10.1016/0301-0511(86)90081-5 · DOI · Paper page
  52. Troy, 2000, J Clin Psychopharmacol, 20, 328, 10.1097/00004714-200006000-00007 · DOI
  53. File, 1982, Br J Clin Pharmacol, 14, 545, 10.1111/j.1365-2125.1982.tb02026.x · DOI
  54. Beer, 1994, J Clin Pharmacol, 34, 335, 10.1002/j.1552-4604.1994.tb02002.x · DOI
  55. Rush, 1999, Psychopharmacology (Berl), 145, 39, 10.1007/s002130051030 · DOI
  56. Isawa, 2000, Nihon Shinkei Seishin Yakurigaku Zasshi, 20, 61
  57. Dingemanse, 2000, Drug Metab Dispos, 28, 1411, 10.1016/S0090-9556(24)13668-9 · DOI
  58. Dingemanse, 1995, Psychopharmacology (Berl), 122, 169, 10.1007/BF02246091 · DOI
  59. Greenblatt, 2000, J Pharmacol Exp Ther, 293, 435, 10.1016/S0022-3565(24)39253-5 · DOI
  60. Subhan, 1984, Neuropsychobiology, 12, 244, 10.1159/000118146 · DOI
  61. Morton, 1992, Pharmacopsychiatry, 25, 177, 10.1055/s-2007-1014402 · DOI
  62. Vidailhet, 1996, Psychopharmacology (Berl), 127, 63, 10.1007/BF02805976 · DOI
  63. Greenblatt, 1998, Clin Pharmacol Ther, 64, 553, 10.1016/S0009-9236(98)90139-4 · DOI
  64. Allen, 1993, Eur J Clin Pharmacol, 45, 313, 10.1007/BF00265947 · DOI
  65. Bhatia, 2001, Psychiatr Serv, 52, 109, 10.1176/appi.ps.52.1.109-a · DOI
  66. Greenblatt, 1991, Clin Pharmacokinet, 21, 262, 10.2165/00003088-199121040-00003 · DOI · Paper page
  67. Greenblatt, 1991, Clin Pharmacokinet, 21, 165, 10.2165/00003088-199121030-00002 · DOI · Paper page
  68. Rosen, 1999, Biopharm Drug Dispos, 20, 171, 10.1002/(SICI)1099-081X(199904)20:3<171::AID-BDD169>3.0.CO;2-K · DOI
  69. Durand, 1992, Drug Metab Rev, 24, 239, 10.3109/03602539208996294 · DOI
  70. Patat, 1994, Psychopharmacology (Berl), 114, 138, 10.1007/BF02245455 · DOI
  71. Fernandez, 1995, Clin Pharmacokinet, 29, 431, 10.2165/00003088-199529060-00004 · DOI · Paper page
  72. Renwick, 1998, Xenobiotica, 28, 337, 10.1080/004982598239452 · DOI
  73. Houghton, 1985, Int J Clin Pharmacol Ther Toxicol, 23, 97
  74. Fernandez, 1993, Drug Metab Dispos, 21, 1125
  75. Parker, 1983, Br J Clin Pharmacol, 16, 259, 10.1111/j.1365-2125.1983.tb02159.x · DOI
  76. Fillastre, 1993, Fundam Clin Pharmacol, 7, 1, 10.1111/j.1472-8206.1993.tb00212.x · DOI
  77. Pacifici, 1988, Int J Clin Pharmacol Ther Toxicol, 26, 439
  78. Hetta, 2000, Eur J Clin Pharmacol, 56, 211, 10.1007/s002280000129 · DOI
  79. Sanchez Garcia, 2000, Am J Health Syst Pharm, 57, 2267, 10.1093/ajhp/57.24.2267 · DOI
  80. Sanchez Garcia, 2000, Am J Health Syst Pharm, 57, 1137, 10.1093/ajhp/57.12.1137 · DOI
  81. Allard, 1999, J Clin Pharmacol, 39, 184, 10.1177/00912709922007624 · DOI
  82. Greenblatt, 1998, Clin Pharmacol Ther, 64, 661, 10.1016/S0009-9236(98)90057-1 · DOI
  83. Villikka, 1997, Clin Pharmacol Ther, 62, 629, 10.1016/S0009-9236(97)90082-5 · DOI
  84. Hulhoven, 1988, Int J Clin Pharmacol Res, 8, 471
  85. Villikka, 1997, Br J Clin Pharmacol, 43, 471, 10.1046/j.1365-2125.1997.00579.x · DOI
  86. Jalava, 1996, Eur J Clin Pharmacol, 51, 331, 10.1007/s002280050207 · DOI
  87. Aranko, 1994, Br J Clin Pharmacol, 38, 363, 10.1111/j.1365-2125.1994.tb04367.x · DOI
  88. Alderman, 2001, Ann Pharmacother, 35, 1378, 10.1345/aph.1A074 · DOI
  89. Patat, 2001, Hum Psychopharmacol, 16, 369, 10.1002/hup.310 · DOI
  90. Sanger, 1994, Neurosci Biobehav Rev, 18, 355, 10.1016/0149-7634(94)90049-3 · DOI · Paper page
  91. Sanna, 2002, Eur J Pharmacol, 451, 103, 10.1016/S0014-2999(02)02191-X · DOI · Paper page
  92. Stanski, 1979, Anesthesiology, 51, 235, 10.1097/00000542-197909000-00011 · doi:10.1097/00000542-197909000-00011
  93. Sheiner, 1979, Clin Pharmacol Ther, 25, 358, 10.1002/cpt1979253358 · DOI · Paper page
  94. Wada, 1998, Clin Pharmacokinet, 35, 1, 10.2165/00003088-199835010-00001 · doi:10.2165/00003088-199835010-00001

Cited by

See all 248

Metadata

Authors
Drover, D. R.
Venue
Clinical Pharmacokinetics
Published
2004
Volume
43
Issue
4
Pages
227-238
ISSN
0312-5963 (ISSN-L)
OpenAlex
W187579988
Cited by
248
References
3
FWCI
20.43
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparative Pharmacokinetics and Pharmacodynamics of Short-Acting Hypnosedatives: Zaleplon, Zolpidem and Zopiclone. https://app.cochat.ai/papers/10.2165/00003088-200443040-00002
The paper
Drover, D. R. (2004). Comparative Pharmacokinetics and Pharmacodynamics of Short-Acting Hypnosedatives: Zaleplon, Zolpidem and Zopiclone. Clinical Pharmacokinetics. https://doi.org/10.2165/00003088-200443040-00002

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.